Main Article Content
Currently, RA is a chronic systemic inflammatory disease that affects not only the joint and periarticular tissues, but also the central and autonomic nervous system, endocrine systems and their interrelationships, and further complicates the course of the underlying disease. Clinicians are familiar with pathologies such as goitre, hypothyroidism, adrenal gland dysfunction, which are common pathologies of endocrine glands in patients with RA. The principles of treating patients with rheumatoid arthritis and autoimmune thyroiditis are one of the complex problems of modern rheumatology. Its relevance is the progression of two autoimmune diseases (RA and AIT), the severity of damage to the musculoskeletal system, the high number of injuries among the working population, early decline in functional ability, loss of professional and social skills, difficulty in physical and psychological adaptation in patients with loss of motor function, It is defined as a general medical and social problem that causes significant economic loss, ie disability.
Prolongation and acceleration of the duration of the main disease leads to the development of thyroid pathology, the addition of new joints and extra-articular systems to the pathological process, the formation of irreversible, permanent changes in the joints (destruction, half-extinction, contracture). All this leads to severe functional deficiency, disruption of all aspects of life and a decrease in the quality of life of patients.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.